These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 20225623

  • 1. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ, Zhang J, Liu WL, Sun ZH, Gu ZL, Jiang XG.
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [Abstract] [Full Text] [Related]

  • 2. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
    Mastropaolo J, Rosse RB, Deutsch SI.
    Behav Brain Res; 2004 Aug 31; 153(2):419-22. PubMed ID: 15265637
    [Abstract] [Full Text] [Related]

  • 3. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC.
    Int Rev Neurobiol; 2007 Aug 31; 78():69-108. PubMed ID: 17349858
    [Abstract] [Full Text] [Related]

  • 4. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY, Lichy JH, Mastropaolo J, Rosse RB, Deutsch SI.
    Eur Neuropsychopharmacol; 2008 Nov 31; 18(11):814-9. PubMed ID: 18674888
    [Abstract] [Full Text] [Related]

  • 5. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH.
    Pharmacopsychiatry; 1998 Jul 31; 31 Suppl 2():104-9. PubMed ID: 9754841
    [Abstract] [Full Text] [Related]

  • 6. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
    Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C.
    Neurosci Biobehav Rev; 2008 Jul 31; 32(5):1014-23. PubMed ID: 18471877
    [Abstract] [Full Text] [Related]

  • 7. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?
    Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St Peter H, Olney JW.
    Biol Psychiatry; 1995 Dec 15; 38(12):788-96. PubMed ID: 8750036
    [Abstract] [Full Text] [Related]

  • 8. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
    Baier PC, Blume A, Koch J, Marx A, Fritzer G, Aldenhoff JB, Schiffelholz T.
    Behav Brain Res; 2009 Dec 14; 205(1):96-101. PubMed ID: 19539658
    [Abstract] [Full Text] [Related]

  • 9. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
    Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Möller HJ, Grunze H.
    Biol Psychiatry; 2006 Apr 15; 59(8):721-9. PubMed ID: 16427029
    [Abstract] [Full Text] [Related]

  • 10. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
    Wedzony K, Fijal K, Mackowiak M, Chocyk A, Zajaczkowski W.
    Neuroscience; 2008 Jun 02; 153(4):1370-9. PubMed ID: 18434025
    [Abstract] [Full Text] [Related]

  • 11. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM, Steele TD, Sharpe LG.
    J Pharmacol Exp Ther; 1997 Jan 02; 280(1):46-52. PubMed ID: 8996180
    [Abstract] [Full Text] [Related]

  • 12. Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.
    O'Tuathaigh CM, Harte M, O'Leary C, O'Sullivan GJ, Blau C, Lai D, Harvey RP, Tighe O, Fagan AJ, Kerskens C, Reynolds GP, Waddington JL.
    Eur J Neurosci; 2010 Jan 02; 31(2):349-58. PubMed ID: 20074216
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A, Giuffrida A.
    Behav Brain Res; 2009 Dec 07; 204(2):410-5. PubMed ID: 19716985
    [Abstract] [Full Text] [Related]

  • 14. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
    Mouri A, Noda Y, Enomoto T, Nabeshima T.
    Neurochem Int; 2007 Dec 07; 51(2-4):173-84. PubMed ID: 17669558
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA, Waters CA, Szeliga KT, Jordan K, Grant KA.
    Psychopharmacology (Berl); 2002 Jul 07; 162(3):273-81. PubMed ID: 12122485
    [Abstract] [Full Text] [Related]

  • 16. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
    Large CH.
    J Psychopharmacol; 2007 May 07; 21(3):283-301. PubMed ID: 17591656
    [Abstract] [Full Text] [Related]

  • 17. Brain NMDA Receptors in Schizophrenia and Depression.
    Adell A.
    Biomolecules; 2020 Jun 23; 10(6):. PubMed ID: 32585886
    [Abstract] [Full Text] [Related]

  • 18. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
    Jentsch JD, Roth RH.
    Neuropsychopharmacology; 1999 Mar 23; 20(3):201-25. PubMed ID: 10063482
    [Abstract] [Full Text] [Related]

  • 19. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A, Saoud M, Khiari G, d'Amato T, Dalery J, Gaha L.
    Encephale; 2001 Mar 23; 27(1):53-9. PubMed ID: 11294039
    [Abstract] [Full Text] [Related]

  • 20. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
    Pinault D.
    Biol Psychiatry; 2008 Apr 15; 63(8):730-5. PubMed ID: 18022604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.